Sustained Viral Suppression After Switch To Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/Taf) Among Clinical Trial Participants With Preexisting M184v/I

INFECTION(2021)

引用 1|浏览9
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要